| Source HCPCS Code |
|
Target NDC Code |
J9022
Inj, atezolizumab,10 mg
|
⇄
|
50242-0917-01
TECENTRIQ 1,200 MG/20 ML VI
|
| Detail Information |
| Relationship Start Date |
01/01/2018 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
20 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J9022
Inj, atezolizumab,10 mg
|
⇄
|
50242-0918-01
TECENTRIQ 840 MG/14 ML VIAL
|
| Detail Information |
| Relationship Start Date |
03/19/2019 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
14 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J9022
Inj, atezolizumab,10 mg
|
⇄
|
50242-0917-01
Tecentriq
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J9022
Inj, atezolizumab,10 mg
|
⇄
|
50242-0918-01
Tecentriq
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|